The future of pharmaceuticals
begins at our industry-leading
manufacturing facility

Industry-leading sterile injectable manufacturing facility

Cutting edge technology guarantees the highest quality of products produced at our state-of-the-art facility located in Pleasant Prairie, Wisconsin. Our three-story, 84,000 sq. ft., high-tech manufacturing facility is ground zero for establishing generic pharmaceutical manufacturing for the U.S.

“As a pharmaceutical company with a significant focus on sterile injectable medicines, we understand the growing patient demand for high quality and accessible generic injections. With the addition of our new manufacturing facility, we are committed to providing a more stable and reliable supply of sterile injectables–a category that is particularly susceptible to drug shortages.”

Shahid Ahmed

Chief Scientific Officer

A significant investment to
create a positive impact

People

People-centric environment designed to create wellness and positive culture

Competitive salary and healthcare benefits for employees

Community

$250M investment over 10 years

77 new local jobs by the end of 2022, 400+ jobs in total

Partnering with local universities for technical training

Environment

Green construction to reduce wastage

Installing Eco and energy friendly manufacturing equipment

Drug shortages have been occurring for far too long

Every day, clinicians wonder if they will have the necessary medicines to treat the patients that they serve. While the COVID-19 pandemic may have drawn attention to the importance of domestic drug manufacturing, this has been a priority of ours since our inception.

In 2019, our dream became a reality as we broke ground on the first project of its kind in the last 30 years, and in 2021, we opened doors to our state-of-the-art manufacturing facility located in Pleasant Prairie, Wisconsin. Commercial production is expected to commence in 2023.

We have invested over $100 million to build a pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin that will provide hospitals access to affordable critical need medication.

We've combined our expertise in development and manufacturing with advanced technological capabilities, innovative approaches, and business models to overcome development hurdles and
speed-to-market.

Our 84,000 sq. ft.
state-of-the-art facility consists of:

Manufacturing

Packaging

Analytical, Environmental, & Microbial Testing

Support Utilities
Warehousing

Read what the Kenosha Area Business Alliance has to say about Nexus Pharmaceuticals’ commitment to innovation, quality, and safety with our new facility.
React transport logo image only